You are viewing: Italy Remote Patient Monitoring (RPM) Market analysis

The Italy Remote Patient Monitoring (RPM) Market was valued at $692.3 Million in 2026 and projected to reach to $1093.2 Million by 2031, representing a compound annual growth rate of 9.6%. Italy's Remote Patient Monitoring market is positioned for sustained growth as the country's aging population and prevalence of chronic diseases drive demand for continuous health monitoring solutions.

Italy Remote Patient Monitoring (RPM) Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Italy Remote Patient Monitoring (RPM) Market Trends and Insights

  • This represents a compound annual growth rate (CAGR) of 9.6%, reflecting Italy's increasing adoption of digital health technologies and chronic disease management solutions.
  • Italy's healthcare system is progressively integrating RPM platforms to enhance patient outcomes, reduce hospital readmissions, and optimize resource allocation across its aging population. The Italian RPM market is driven by regulatory support, rising prevalence of chronic conditions, and growing investment in healthcare digitalization.
  • Italy's commitment to modernizing its National Health Service (NHS) has created favorable conditions for RPM deployment across cardiology, diabetes management, and respiratory care segments.
  • Between 2026 and 2031, Italy is expected to see accelerated adoption among both public healthcare providers and private institutions, supported by reimbursement policies and patient demand for remote monitoring capabilities. Italy's market trajectory reflects broader European trends while maintaining distinct characteristics tied to its healthcare infrastructure and demographic profile.
  • The country's focus on cost-effective care delivery and aging population management positions RPM as a critical component of Italy's future healthcare strategy through 2031..

Key Market Statistics

  • CAGR (2026-2031) 9.6% CAGR
  • Market Size, 2026 ~USD 692.3 Million
  • Forecast, 2031 ~USD 1093.2 Million
  • Country Italy

Italy Remote Patient Monitoring (RPM) Market Overview

Market Valuation Growth :

Italy's RPM market is valued at USD 692.3 million in 2026 and is projected to reach USD 1,093.2 million by 2031, demonstrating robust expansion in digital health adoption across the country.

Steady CAGR Performance :

With a CAGR of 9.6% from 2026 to 2031, Italy's RPM market growth outpaces many European counterparts, driven by aging demographics and increased healthcare digitalization initiatives.

Healthcare System Integration :

Italy's national healthcare system is progressively integrating RPM platforms for chronic disease management, particularly for cardiovascular, respiratory, and diabetes monitoring applications.

Digital Health Adoption :

Rising government support for telemedicine and remote monitoring solutions, combined with patient demand for convenient care delivery, is accelerating RPM technology penetration across Italian healthcare providers.

Italy Remote Patient Monitoring (RPM) Market Dynamics

  • Healthcare providers are increasingly recognizing RPM's potential to reduce hospital readmissions, improve patient outcomes, and optimize resource allocation within Italy's public healthcare system. Government initiatives promoting digital health infrastructure and reimbursement policies supporting remote monitoring services are expected to further accelerate market expansion.
  • Italian healthcare organizations are investing in RPM platforms to enhance patient engagement and enable proactive disease management, particularly in underserved regions.
  • This convergence of regulatory support, technological advancement, and clinical demand positions Italy as a key growth market for RPM solutions in Southern Europe..

Related Ecosystem

Cardiovascular Devices

Top Technologies
    Top Companies

      Diagnostic Imaging

      Top Technologies
        Top Companies

          Healthcare It

          Top Technologies
            Top Companies

              Key Takeaways

              • Italy's RPM market will grow from $692.3M (2026) to $1,093.2M (2031) at a 9.6% CAGR, driven by digital health adoption and chronic disease management needs.
              • Italy's aging population and healthcare cost pressures are accelerating RPM implementation across cardiology, diabetes, and respiratory care segments.
              • Regulatory support and NHS modernization initiatives in Italy are creating favorable reimbursement and deployment conditions for RPM solutions.
              • Italy's RPM market growth is supported by increasing patient demand for remote monitoring and healthcare provider investment in digital infrastructure.

              Remote Patient Monitoring (RPM) Market Report Scope

              Report Metric Details
              Base Year 2026
              Fastest Growing Segment SYNCHRONOUS (Transmission Type)
              Forecast Period 2026–2031
              Growth Rate CAGR of 12.8% from 2026 to 2031
              Largest Segment HEALTHCARE PROVIDERS (End User)
              Market Size Base Year (Billions) ~USD 36.32 (2026)
              Revenue Forecast (Billions) ~USD 66.33 (2031)
              Segments Covered Component, Function, Type, Deployment Model, Transmission Type, Indication, End User, Deployment Type

              Italy Remote Patient Monitoring (RPM) Market Report Segmentation

              8 segment dimensions are covered across the global market.

              By Component

              • Devices
              • Services
              • Software

              By Function

              • Blood Glucose Monitoring
              • Cardiac Monitoring
              • Fetal & Neonatal Monitoring
              • Multiparameter Monitoring
              • Neurological Monitoring
              • Other Monitoring Devices
              • Pulse Oximeters
              • Respiratory Monitoring
              • Thermometers
              • Weight Monitoring

              By Type

              • Ambulatory Surgical Centers, Ambulatory Care Centers, And Other Outpatient Settings
              • Handheld & Portable
              • Handheld & Portable Devices
              • Home Healthcare
              • Hospitals
              • Implantable
              • Implantable Devices
              • Long-Term Care & Assisted Living Facilities
              • Other Healthcare Providers
              • Others (Stationary Devices And Others)
              • Others (Stationary Devices, And Others)
              • Wearable
              • Wearable Devices

              By Deployment Model

              • Cloud-Based Model
              • On-Premise Model

              By Transmission Type

              • Asynchronous
              • Synchronous

              By Indication

              • Cardiology
              • Diabetes
              • Mental Health
              • Neurology
              • Oncology
              • Other Indications
              • Respiratory Disorders
              • Sleep Disorders
              • Wellness Improvement

              By End User

              • Healthcare Payers
              • Healthcare Providers
              • Medtech Companies
              • Other End Users
              • Patients
              • Pharmaceutical & Biotechnology Companies

              By Deployment Type

              • Cloud-Based
              • On-Premises

              ITALY: REMOTE PATIENT MONITORING MARKET, BY END USER, 2024–2031

              Segment20242025202620272028202920302031CAGR (%)
              HEALTHCARE PAYERS111.8124.8138.6153.2168.8185.3202.62219.8
              HEALTHCARE PROVIDERS253.3282312.1344377.8413.5450.9490.49.5
              MEDTECH COMPANIES27.530.433.536.840.243.747.551.48.9
              OTHER END USERS12.313.514.816.217.61920.421.98.1
              PATIENTS110.8124138.1153.2169.2186.3204.4223.710.1
              PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES45.15055.160.566.272.178.384.89
              TOTAL560.6624.8692.3763.8839.7919.91004.21093.29.6

              Target Audience

              • Healthcare Technology Vendors : RPM solution providers and digital health companies need Italy-specific market data to develop localized products, establish distribution channels, and capture market share in this growing Southern European market.
              • Healthcare Providers & Hospitals : Italian hospitals, clinics, and healthcare networks require market intelligence to evaluate RPM adoption strategies, benchmark against peers, and make informed technology investment decisions for patient care delivery.
              • Private Equity & Investors : Investment firms and venture capitalists focused on healthcare technology need detailed Italy market analysis to identify acquisition targets, assess growth potential, and evaluate return on investment in the RPM sector.
              • Government & Policy Makers : Italian healthcare authorities and policymakers need market insights to develop digital health strategies, allocate resources effectively, and establish reimbursement frameworks supporting RPM adoption.
              • Pharmaceutical & Medical Device Companies : Pharma and device manufacturers need Italy RPM market data to understand patient monitoring trends, identify partnership opportunities, and integrate their products with remote monitoring platforms.

              Key Companies in the Italy Remote Patient Monitoring (RPM) Market

              CompanyHQOwnershipStrongest segments
              KONINKLIJKE PHILIPS N.V.NetherlandsPublic CompanyDiagnosis & Treatment (Imaging and Image Guided Therapy),Connected Care (Monitoring, Enterprise Informatics, Sleep and Respiratory Care),Personal Health,
              MEDTRONICIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Diabetes and Monitoring),
              GE HEALTHCAREUnited StatesPublic CompanyImaging,Advanced Visualization Solutions (AVS),Patient Care Solutions (PCS),
              ABBOTTUnited StatesPublic CompanyDiagnostic Products,Medical Devices,Nutritional Products,
              ORACLEUnited StatesPublic CompanyCloud Applications (Fusion ERP/EPM/SCM/HCM, NetSuite, CX, Health),Database and Infrastructure Technologies (Oracle DB, MySQL, Autonomous, Middleware, Java),Cloud Infrastructure (Compute, Storage, Networking, AI/ML, Digital Assistant, Blockchain),
              BOSTON SCIENTIFIC CORPORATIONUnited StatesPublic CompanyCardiovascular (structural heart, CRM, LAAC, peripheral interventions),MedSurg – Endoscopy (GI, pancreaticobiliary, infection prevention, single-use scopes),MedSurg – Urology and Pelvic Health,
              NIHON KOHDEN CORPORATIONJapanPublic CompanyPatient monitors and clinical information systems,Physiological measuring equipment (EEG, ECG, EMG, polygraphs),Defibrillators, AEDs, and resuscitation devices,
              SIEMENS HEALTHINEERS AGGermanyPublic CompanyImaging,Diagnostics,Varian (Oncology),
              BAXTERUnited StatesPublic CompanyMedical Products & Therapies (IV solutions, infusion, parenteral nutrition, renal and related therapies),Healthcare Systems & Technologies (smart beds, monitoring, OR integration, surgical equipment, respiratory devices),Pharmaceuticals (generic and specialty injectables, inhaled anesthetics, compounding services),

              KONINKLIJKE PHILIPS N.V.

              Koninklijke Philips N.V. is a Dutch multinational public company founded in 1891 with 64,317 employees, operating across healthcare and technology sectors.

              MEDTRONIC

              Medtronic is a public medical technology company founded in 1949 in Ireland with 95,000 employees, providing medical devices and healthcare solutions.

              GE HEALTHCARE

              GE Healthcare is a public healthcare company established in 2022 in the United States with 54,000 employees, offering medical imaging and healthcare technology.

              ABBOTT

              Abbott is a public healthcare and diagnostics company founded in 1888 in the United States with 115,000 employees.

              ORACLE

              Oracle is a public software and cloud computing company founded in 1977 in the United States with 141,000 employees.

              BOSTON SCIENTIFIC CORPORATION

              Boston Scientific Corporation is a public medical device company founded in 1979 in the United States with 59,000 employees.

              NIHON KOHDEN CORPORATION

              Nihon Kohden Corporation is a Japanese public company founded in 1951 with 6,116 employees, specializing in medical equipment and healthcare technology.

              SIEMENS HEALTHINEERS AG

              Siemens Healthineers AG is a German public healthcare company founded in 1896 with 72,369 employees, providing medical imaging and diagnostic solutions.

              BAXTER

              Baxter is a public healthcare company founded in 1931 in the United States with 37,500 employees, specializing in medical devices and pharmaceuticals.

              Reasons to Buy this Report

              • Market Entry Strategy : Gain comprehensive insights into Italy's RPM market dynamics, competitive landscape, and growth drivers to develop targeted market entry strategies and identify partnership opportunities with Italian healthcare providers.
              • Investment Decision Support : Access detailed financial projections and market valuation data for Italy's RPM sector to support investment decisions, funding allocation, and portfolio diversification in Southern European healthcare technology.
              • Regulatory & Reimbursement Landscape : Understand Italy-specific regulatory frameworks, reimbursement policies, and healthcare system requirements that impact RPM adoption, enabling compliant product development and market positioning.
              • Competitive Benchmarking : Analyze Italy's competitive environment, key market players, and differentiation opportunities to benchmark your offerings against local and international competitors operating in the Italian RPM market.
              • Growth Opportunity Identification : Identify high-potential segments, underserved patient populations, and emerging use cases within Italy's healthcare system to prioritize product development and commercial expansion initiatives.

              Frequently asked questions

              What is the projected market size of RPM in Italy by 2031?

              Italy's RPM market is forecast to reach USD 1,093.2 million by 2031, growing from USD 692.3 million in 2026 at a 9.6% CAGR.

              What are the primary drivers of RPM adoption in Italy?

              Italy's RPM market growth is driven by an aging population, rising chronic disease prevalence, healthcare cost pressures, regulatory support, and NHS digitalization initiatives.

              Which medical segments are leading RPM adoption in Italy?

              Cardiology, diabetes management, and respiratory care are among the leading segments driving RPM adoption across Italy's healthcare system.

              How is Italy's healthcare system supporting RPM implementation?

              Italy's National Health Service is modernizing through digital health investments, reimbursement policies, and regulatory frameworks that facilitate RPM deployment in both public and private healthcare settings.

              What is the CAGR for Italy's RPM market between 2026 and 2031?

              Italy's RPM market is expected to grow at a compound annual growth rate (CAGR) of 9.6% from 2026 to 2031.

              RESEARCH METHODOLOGY

              The study involved major activities in estimating the current market size for the remote patient monitoring market.

              Exhaustive secondary research was done to collect information on the remote patient monitoring industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the remote patient monitoring market.  

              Secondary Research

              In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to in order to identify and collect information for the study of the remote patient monitoring market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

              Primary Research

              Extensive primary research was conducted after acquiring basic knowledge about the global remote patient monitoring market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (Hospital directors, Hospital Vice Presidents, Department heads, and Critical care specialists ) and supply side (such as C-level and D-level executives, technology experts, product managers, marketing and sales managers, among others) across five major regions—North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

              BREAKDOWN OF PRIMARY INTERVIEW PARTICIPANTS

              Remote Patient Monitoring Market 
 Size, and Share

              Note 1: Others include sales managers, marketing managers, and product managers.

              Note 2: Tiers of companies are defined on the basis of their total revenues in 2025. Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

              To know about the assumptions considered for the study, download the pdf brochure

              Market Size Estimation

              Both top-down and bottom-up approaches were used to estimate and validate the total size of the remote patient monitoring market. These methods were also used extensively to estimate the size of various subsegments in the market.

               The research methodology used to estimate the market size includes the following:

              Remote Patient Monitoring Market Top Down and Bottom Up Approach

              Data Triangulation

              After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the remote patient monitoring market.

              Market Definition

              The remote patient monitoring (RPM) market involves the use of technology to remotely monitor and manage patients' health conditions outside of traditional healthcare settings, as well as in patient settings. It leverages devices such as wearables, sensors, and mobile applications to track vital signs and chronic diseases. RPM allows healthcare providers to access real-time data for better decision-making and personalized care.

              Key Stakeholders

              • RPM Equipment and devices Manufacturers
              • Suppliers and Distributors of RPM Equipment
              • RPM software provider
              • Healthcare IT Service Providers
              • Healthcare Insurance Companies/Payers
              • Healthcare Institutions/Providers (Hospitals, Clinics, Medical Groups, Physician Practices, Diagnostic Centers, and Outpatient Clinics)
              • Venture Capitalists
              • Government Bodies/Regulatory Bodies
              • Corporate Entities
              • Accountable Care Organizations
              • RPM Resource Centers
              • Research and Consulting Firms
              • Medical Research Institutes
              • Clinical Departments

              Report Objectives

              • To define, describe, and forecast the global remote patient monitoring market based on component, indication, end user, and region.
              • To provide detailed information regarding the major factors (such as drivers, restraints, opportunities, and challenges) influencing the market growth
              • To strategically analyze micro-markets with respect to individual growth trends, prospects, and contributions to the overall remote patient monitoring market
              • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders.
              • To strategically analyze the market structure profile of the key players of the remote patient monitoring market and comprehensively analyze their core competencies.
              • To forecast the size of the market segments with respect to five regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
              • To track and analyze competitive developments such as product launches and enhancements, investments, partnerships, collaborations, acquisitions, expansions, funding, grants, agreements, sales contracts, product testing, FDA approval, product approval, and alliances in the remote patient monitoring market during the forecast period.

              Available customizations:

              With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

              • Product Analysis: Product matrix, which gives a detailed comparison of the product portfolios of each company.
              • Geographic Analysis:  Further breakdown of Latin American remote patient monitoring into specific countries, the Middle East, and Africa remote patient monitoring into specific countries, and further breakdown of European remote patient monitoring into specific countries

               

              Get the Full Remote Patient Monitoring (RPM) Market Report

              Full forecast, segment splits, and company analysis for all Remote Patient Monitoring (RPM) Market.

              Need a Tailored Report?

              Customize this report to your needs

              Get 10% FREE Customization

              Customize This Report
              Fact checked
              DMCA.com Protection Status